Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Vered Caplan | F | 55 | 12 ans | |
David Sidransky | M | 64 | 11 ans | |
Mario Philips | M | 54 | 4 ans | |
Yaron Adler | M | 54 | 12 ans | |
Guy Yachin | M | 55 | 12 ans | |
Sarah Ferber | M | 70 | 16 ans | |
Ashish Nanda | M | 59 | 7 ans | |
Victor Miller | M | 54 | - | |
Gerhard Bauer | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Neil Reithinger | M | 54 | 9 ans | |
Elliot Maltz | M | 39 | - | |
Manfred Rüdiger | M | 59 |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | 5 ans |
Claudia Zylberberg | M | - | - | |
Osher Rheinisch | F | 52 | 1 ans | |
Thomas Schulze | M | 61 |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development. | 7 ans |
Thomas Mathers | M | 56 |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | 1 ans |
Thomas H. Moll | M | 58 |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | 5 ans |
Efrat Assa-Kunik | M | 49 | 2 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 14 | 77,78% |
Allemagne | 4 | 22,22% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Heiko von der Leyen
- Réseau Personnel